| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/11/1994 | US5277893 Direct radiolabeling of substrates containing monosulfides or disulfide bonds with radionuclides |
| 01/11/1994 | US5277892 Administering a mixture of a lectin and a linked imaging ion |
| 01/11/1994 | US5277818 Ion exchanging separation by an anionic exchanger |
| 01/11/1994 | EP0585375A4 Plant defense gene(s) and regulatory element(s). |
| 01/11/1994 | CA1326109C Sv40 expression vector containing hbxag as an expression marker |
| 01/11/1994 | CA1326107C Heterocyclic ketones |
| 01/11/1994 | CA1326106C Production of proteins in active forms |
| 01/08/1994 | CA2099967A1 Process for recovering peptides expressed as fusion proteins |
| 01/06/1994 | WO1994000766A1 Gravidin: assays, dna fragments or genes and uses thereof |
| 01/06/1994 | WO1994000764A1 The met proto-oncogene and a method for predicting breast cancer progression |
| 01/06/1994 | WO1994000603A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 01/06/1994 | WO1994000601A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 01/06/1994 | WO1994000599A2 Process for detection of neoplastic disease |
| 01/06/1994 | WO1994000596A1 Acceptor for fucosyltransferase |
| 01/06/1994 | WO1994000594A1 Methods for using cks fusion proteins |
| 01/06/1994 | WO1994000590A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/06/1994 | WO1994000588A1 Protein based delivery system |
| 01/06/1994 | WO1994000587A2 Attenuated equine herpesvirus-4 as live vaccine or recombinant vector |
| 01/06/1994 | WO1994000586A2 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 01/06/1994 | WO1994000585A1 Recombinant baculoviruses containing insect cellular promoter |
| 01/06/1994 | WO1994000582A2 A method for obtaining a plant having altered floral morphology and a method for protecting plants against pest insects |
| 01/06/1994 | WO1994000581A1 Lactobacillus expression system using surface protein gene sequences |
| 01/06/1994 | WO1994000575A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 01/06/1994 | WO1994000574A1 Dna sequences encoding oligosaccharide transporter |
| 01/06/1994 | WO1994000573A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | WO1994000572A2 Gene for ataxia-telangiectasia complementation group d (atdc) |
| 01/06/1994 | WO1994000571A1 Soluble cr1 derivatives |
| 01/06/1994 | WO1994000570A1 Mammalian growth factor |
| 01/06/1994 | WO1994000569A1 Methods for producing transgenic non-human animals harboring a yeast artificial chromosome |
| 01/06/1994 | WO1994000568A1 Hiv-sensitive transgenic rabbit, use thereof as an animal model, and method for obtaining same |
| 01/06/1994 | WO1994000562A1 A novel human immunodeficiency virus |
| 01/06/1994 | WO1994000560A1 Matrix for universal donor microvascular endothelial cells |
| 01/06/1994 | WO1994000558A1 DIABETOGENE rad: A TYPE II DIABETES SPECIFIC GENE |
| 01/06/1994 | WO1994000557A1 Method for preparing membrane proteins and preserving their oligomeric structures under denaturing conditions, and uses of said proteins in diagnostics and vaccination |
| 01/06/1994 | WO1994000556A1 Fusobacterium necrophorum leukotoxoid vaccine |
| 01/06/1994 | WO1994000555A2 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | WO1994000509A1 Oxazolone derived materials |
| 01/06/1994 | WO1994000494A1 Improvements in or relating to neuroregeneration |
| 01/06/1994 | WO1994000493A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | WO1994000492A1 Angiotensin iv peptides and receptor |
| 01/06/1994 | WO1994000491A1 INTERLEUKIN-1β DELETION MUTANT |
| 01/06/1994 | WO1994000489A2 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
| 01/06/1994 | WO1994000488A1 Anti-hiv peptide or peptide derivative |
| 01/06/1994 | WO1994000487A1 Peptide which produces protective immunity against tetanus |
| 01/06/1994 | WO1994000486A1 Neuropeptide y antagonists |
| 01/06/1994 | WO1994000485A1 Multimeric forms of human rhinovirus receptor protein |
| 01/06/1994 | WO1994000484A1 Scar inhibitory factor and use thereof |
| 01/06/1994 | WO1994000483A1 PURIFICATION OF KRINGLE CONTAINING PROTEINS, AND ESPECIALLY t-PA |
| 01/06/1994 | WO1994000482A1 Isolation and characterization of the growth hormone releasing hormone receptor |
| 01/06/1994 | WO1994000481A1 Pharmaceutical composition containing botulinum b complex |
| 01/06/1994 | WO1994000469A1 Novel tyrosine kinase |
| 01/06/1994 | WO1994000464A1 Deproteinization with azlactone-functional supports |
| 01/06/1994 | WO1994000151A1 Combinatorial polypeptide antigens |
| 01/06/1994 | WO1994000150A1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 01/06/1994 | WO1994000149A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 01/06/1994 | WO1994000148A1 Synthetic peptides for the treatment of myasthenia gravis |
| 01/06/1994 | WO1994000146A1 Treatment for sensitive teeth |
| 01/06/1994 | WO1994000144A1 Anti-aggregatory agents for platelets |
| 01/06/1994 | WO1994000143A1 Blocking intercellular interactions with cd43 chimeric molecules |
| 01/06/1994 | WO1994000140A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | WO1994000133A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression |
| 01/06/1994 | WO1994000131A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 01/06/1994 | WO1993023434A3 Bpi-immunoglobulin fusion proteins |
| 01/06/1994 | WO1993021331A3 Polysaccharide binding fusion proteins and conjugates |
| 01/06/1994 | WO1993016726A3 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 01/06/1994 | WO1993015207A3 Hepatitis therapeutics |
| 01/06/1994 | WO1993015206A3 Process for controlling scarab pests with bacillus thuringiensis isolates |
| 01/06/1994 | CA2139350A1 Oxazolone derived materials |
| 01/06/1994 | CA2139136A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | CA2139127A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | CA2139105A1 Angiotensin iv peptides and receptor |
| 01/06/1994 | CA2138996A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 01/06/1994 | CA2138988A1 Recombinant baculoviruses containing insect cellular promoter |
| 01/06/1994 | CA2138970A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | CA2138807A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | CA2138414A1 Protein based delivery system |
| 01/06/1994 | CA2138374A1 Neuropeptide y antagonists |
| 01/06/1994 | CA2138281A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 01/06/1994 | CA2137779A1 Purification of kringle containing proteins, and especially t-pa |
| 01/06/1994 | CA2137346A1 Dna sequences encoding oligosaccharide transporter |
| 01/06/1994 | CA2137008A1 Acceptor for fucosyltransferase |
| 01/06/1994 | CA2136986A1 Gene for ataxia-telangiectasia complementation group d (atdc) |
| 01/06/1994 | CA2136765A1 Methods for using cks fusion proteins |
| 01/06/1994 | CA2136439A1 Process for detection of neoplastic disease |
| 01/06/1994 | CA2136432A1 Deproteinization with azlactone-functional supports |
| 01/06/1994 | CA2135313A1 Methods for producing transgenic non-human animals harboring a yeast artificial chromosome |
| 01/06/1994 | CA2116109A1 Multimeric forms of human rhinovirus receptor protein |
| 01/05/1994 | EP0577580A2 Synthesis of sialoconjugates |
| 01/05/1994 | EP0577458A1 Nucleotide and Peptide sequences of the FIV isolate WO and their uses in diagnostic and prevention of the feline immunodeficiency virus infection |
| 01/05/1994 | EP0577257A1 Alpha-amylase from hyperthermophilic archaebacterium |
| 01/05/1994 | EP0577243A2 Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection |
| 01/05/1994 | EP0577224A1 Bacterial antigens, antibodies, vaccines and methods of manufacture |
| 01/05/1994 | EP0577147A2 Method for stabilizing taste-modifier |
| 01/05/1994 | EP0577144A1 Detection of a unique Chlamydia strain associated with acute respiratory disease |
| 01/05/1994 | EP0577028A2 Anti-DCC gene product specific monoclonal antibody |
| 01/05/1994 | EP0576988A1 Isolation and characterization of the growth hormone releasing hormone receptor |
| 01/05/1994 | EP0576898A2 Linear peptides |
| 01/05/1994 | EP0576842A2 Method and means for detecting listeria |
| 01/05/1994 | EP0576792A2 Plasmids and process for producing recombinant desulphatohirudin HV-1 peptide |
| 01/05/1994 | EP0576669A1 Novel methods and compositions for treatment of angiogenic diseases |